Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster - PhysicianPharm

Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR expression and overall survival

Rehab Mostafa, Ahmed Kandeel, Maha Abdelkareem, Lorenzo Nardo and Yasser Abdelhafez
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1045;
Rehab Mostafa
1South Egypt Cancer Institute, Assiut University Assiut Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed Kandeel
2Kasr Eleiny Center of Radiation Oncology and Nuclear Medicine Cairo Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maha Abdelkareem
2Kasr Eleiny Center of Radiation Oncology and Nuclear Medicine Cairo Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Nardo
3UC Davis Sacramento CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasser Abdelhafez
1South Egypt Cancer Institute, Assiut University Assiut Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1045

Purpose: Extraction of stable radiomic features (RFs) from 18F-FDG PET/CT is challenging due to different acquisition, processing and post-processing protocols. In this report, we aimed to evaluate robustness of RFs, extracted using Image Biomarker Standardization Initiative (IBSI)-compliant approach, to 4 different primary tumor segmentation methods, in patients with lung cancer and to assess any association of TFs with specific molecular marker expression and overall survival (OS).

Methods: Under IRB approval, 87 patients (18 females, 69 males; age 60±10 yrs, range: 30-81 yrs) with treatment naïve primary lung cancer were included in this prospective study. All patients underwent a pretherapy 18F-FDG PET/CT using a standardized clinical protocol.Primary tumors were delineated using 4 different segmentation methods: Method 1, manual; Method 2: manual with peripheral 1 mm erosion; Method 3: absolute threshold at SUV 2.5; Method 4: relative threshold at 40% SUVmax.Radiomic features (RFs) were extracted using LifeX v.5.1. PET images were spatially resampled into 3 mm isotropic voxels and the grey levels within the extracted volume of interest (VOI) were normalized between the minimum and maximum SUV values and discretized into 64 bins. A total of 35 RFs per segmentation method were evaluated.Before testing for TF reproducibility, the study cohort was randomly divided into 2 groups (testing & validation) in a ratio of 1:2 (n = 29 & n=58, respectively). Testing cohort was used to identify robust RFs, defined as having a minimum concordance correlation coefficient (CCC) ≥ 0.75 among all the 4-segmetnation methods. The resulting TFs were used for subsequent analysis in the validation cohort (n=58). Association of these quantitative TFs with EGFR expression and other histopathologic characteristics was tested using Mann-Whitney U test. All patients in the validation cohort had a follow-up of 2-years since the date of PET/CT scan or till death. Cox Proportional Hazard model was used to evaluate the association of different RFs with 2-year overall survival (OS).

Results: Testing and validation cohorts were equivalent regarding basic characteristics (age, sex & tumor stage).Twelve RFs were deemed robust to the described 4 segmentation methods: SUV SD, SUVmax, SUVpeak, TLG, histogram energy uniformity, volume, compacity, GLCM energy, GLRLM GLNU, GLRLM RLNU, NGLDM busyness, and GLZLM LZHGE.Shape features (tumor volume and compacity) from any segmentation method were associated with EGFR expression.At the end of 24-months of follow-up, 41 patients died and 17 were still alive (OS=29.3%; median survival = 14.7 months, 95%CI: 10.1-19.3 months). Five TFs were associated with 2-year OS from any of the 4 segmentation methods: TLG, volume, compacity, GLRLM GLNU and GLRLM RLNU. The highest hazard ratio for OS was consistently generated from tumor volume and compacity regardless the segmentation method.

Conclusions: Segmentation method of the primary lung tumors on pretherapy 18F-FDG PET/CT can affect radiomic feature stability. These preliminary results showed that only 12 features were robust enough to 4 different segmentation approaches; two of these features (tumor volume and compacity, which reflects how compact the tumor volume is) showed significant association with EGFR expression and overall survival in patients with lung cancer.Future work will further validate these findings in larger population, add CT features and employ machine learning models to optimize prediction of molecular marker expression and prognosis in terms of response and survival.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR expression and overall survival
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR expression and overall survival
Rehab Mostafa, Ahmed Kandeel, Maha Abdelkareem, Lorenzo Nardo, Yasser Abdelhafez
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1045;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR expression and overall survival
Rehab Mostafa, Ahmed Kandeel, Maha Abdelkareem, Lorenzo Nardo, Yasser Abdelhafez
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1045;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - PhysicianPharm

  • Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
  • A clinical study of baseline PET/CT parameters in the prediction of refractory/ relapsed diffuse large B cell lymphoma of advanced stage patients
  • A head-to-head comparison of the Lugano Classification and PERCIST for FDG-PET/CT response assessment in diffuse large B-cell lymphoma
Show more Poster - PhysicianPharm

Lung Cancer Posters

  • Combining volume based metabolic parameters on preoperative 18F-FDG PET/CT and clinical features could predict lymphovascular invasion in patients with non-small-cell lung cancer
  • Preoperative prediction of meidastinal node metastasis using Radiomics model based on 18F-FDG PET/CT of the primary tumor in non-small cell lung cancer patients
  • Comparison diagnostic value of 18F-FDG PET/MRI and PET/CT in evaluation of pleural invasion in patient with non-small cell lung cancer
Show more Lung Cancer Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire